申请人:GENOMATICA, INC.
公开号:US10351887B2
公开(公告)日:2019-07-16
The invention provides non-naturally occurring microbial organisms containing caprolactone pathways having at least one exogenous nucleic acid encoding a butadiene pathway enzyme expressed in a sufficient amount to produce caprolactone. The invention additionally provides methods of using such microbial organisms to produce caprolactone by culturing a non-naturally occurring microbial organism containing caprolactone pathways as described herein under conditions and for a sufficient period of time to produce caprolactone.
本发明提供了含有己内酯途径的非天然存在的微生物有机体,该有机体具有至少一种编码丁二烯途径酶的外源核酸,其表达量足以生产己内酯。本发明还提供了使用这种微生物生物生产己内酯的方法,即在生产己内酯的条件下,培养含有本文所述己内酯途径的非天然存在的微生物生物足够长的时间,以生产己内酯。